| scholarly article | Q13442814 |
| P2093 | author name string | X Charlie Dong | |
| P2860 | cites work | Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity | Q24298021 |
| The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription | Q24301955 | ||
| Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation | Q24534597 | ||
| Forkhead box transcription factor O1 inhibits cholesterol 7alpha-hydroxylase in human hepatocytes and in high fat diet-fed mice | Q24654808 | ||
| SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation | Q24674602 | ||
| Long live FOXO: unraveling the role of FOXO proteins in aging and longevity | Q26773901 | ||
| Redox regulation of FoxO transcription factors | Q26799843 | ||
| FOXO transcription factors: key regulators of cellular quality control | Q26851722 | ||
| FOXO3: A Major Gene for Human Longevity--A Mini-Review | Q26996592 | ||
| Regulation of sterol carrier protein gene expression by the forkhead transcription factor FOXO3a | Q28210523 | ||
| The FoxO code | Q28275268 | ||
| SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma | Q28301961 | ||
| The autophagy-related gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism | Q28512608 | ||
| Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16 | Q28579390 | ||
| Autophagy regulates lipid metabolism | Q29547421 | ||
| Forkhead transcription factors: key players in development and metabolism | Q29618804 | ||
| The inhibitory effect of ethanol on Sestrin3 in the pathogenesis of ethanol-induced liver injury | Q33840005 | ||
| Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation | Q34089899 | ||
| Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia | Q34094336 | ||
| Deficient chaperone-mediated autophagy in liver leads to metabolic dysregulation | Q34143516 | ||
| Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth | Q34236816 | ||
| FoxOs function synergistically to promote glucose production | Q34284954 | ||
| Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors. | Q34339449 | ||
| Insulin-dependent suppression of cholesterol 7α-hydroxylase is a possible link between glucose and cholesterol metabolisms | Q39329298 | ||
| FOXO1 involvement in insulin resistance-related pro-inflammatory cytokine production in hepatocytes | Q39416732 | ||
| Down-regulation of FoxO-dependent c-FLIP expression mediates TRAIL-induced apoptosis in activated hepatic stellate cells | Q39847039 | ||
| TGFbeta1, TNFalpha, and insulin signaling crosstalk in regulation of the rat cholesterol 7alpha-hydroxylase gene expression | Q39977199 | ||
| Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice | Q40041201 | ||
| FoxO1 stimulates fatty acid uptake and oxidation in muscle cells through CD36-dependent and -independent mechanisms. | Q40462000 | ||
| A forkhead transcription factor FKHR up-regulates lipoprotein lipase expression in skeletal muscle | Q40670804 | ||
| Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice | Q42056919 | ||
| Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis | Q42681991 | ||
| Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes | Q46402217 | ||
| FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression | Q46955933 | ||
| Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver | Q48386175 | ||
| The role of FOXO in the regulation of metabolism. | Q54742441 | ||
| Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis | Q57659886 | ||
| FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages | Q34479950 | ||
| Effects of FoxO4 overexpression on cholesterol biosynthesis, triacylglycerol accumulation, and glucose uptake | Q34559836 | ||
| The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells | Q34615778 | ||
| Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene | Q34800558 | ||
| Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis | Q34981792 | ||
| Insulin regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c. | Q35049218 | ||
| Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in mice | Q35565619 | ||
| A mutant allele encoding DNA binding-deficient FoxO1 differentially regulates hepatic glucose and lipid metabolism | Q35630807 | ||
| Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia | Q35661144 | ||
| Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function | Q35750935 | ||
| Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice. | Q35860656 | ||
| FoxO1 inhibits sterol regulatory element-binding protein-1c (SREBP-1c) gene expression via transcription factors Sp1 and SREBP-1c | Q36016844 | ||
| Loss of Pdk1-Foxo1 signaling in myeloid cells predisposes to adipose tissue inflammation and insulin resistance. | Q36109222 | ||
| The new biology of diabetes | Q36113537 | ||
| Loss of ULK1 increases RPS6KB1-NCOR1 repression of NR1H/LXR-mediated Scd1 transcription and augments lipotoxicity in hepatic cells | Q36193081 | ||
| FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization | Q36584799 | ||
| FOXO animal models reveal a variety of diverse roles for FOXO transcription factors | Q37129810 | ||
| Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism | Q37149810 | ||
| Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6 | Q37163041 | ||
| FoxO3 transcription factor and Sirt6 deacetylase regulate low density lipoprotein (LDL)-cholesterol homeostasis via control of the proprotein convertase subtilisin/kexin type 9 (Pcsk9) gene expression | Q37226067 | ||
| Genetics. Simple genetics for a complex disease | Q37339090 | ||
| Hepatic insulin resistance directly promotes formation of cholesterol gallstones | Q37366384 | ||
| FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages. | Q37400789 | ||
| CBP-mediated FOXO-1 acetylation inhibits pancreatic tumor growth by targeting SirT. | Q37637287 | ||
| Integrated Regulation of Hepatic Lipid and Glucose Metabolism by Adipose Triacylglycerol Lipase and FoxO Proteins | Q37693826 | ||
| FOXO transcription factors protect against the diet-induced fatty liver disease | Q37704641 | ||
| Foxo1 integrates insulin signaling with mitochondrial function in the liver | Q37715192 | ||
| Regulation of FoxO transcription factors by acetylation and protein-protein interactions | Q37852172 | ||
| Forkhead box class O transcription factors in liver function and disease | Q38121578 | ||
| FOXO in aging: did evolutionary diversification of FOXO function distract it from prolonging life? | Q38154207 | ||
| Insulin/insulin-like growth factor-1 signalling (IIS) based regulation of lifespan across species | Q39094521 | ||
| FoxO integration of insulin signaling with glucose and lipid metabolism. | Q39141439 | ||
| AKT/PKB Signaling: Navigating the Network | Q39255027 | ||
| Mechanisms of hepatic stellate cell activation | Q39294420 | ||
| P433 | issue | 3 | |
| P921 | main subject | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
| non-alcoholic fatty liver | Q66299798 | ||
| P304 | page(s) | 168-173 | |
| P577 | publication date | 2017-09-01 | |
| P1476 | title | FOXO transcription factors in non-alcoholic fatty liver disease | |
| P478 | volume | 1 |
| Q92637772 | A Review of FoxO1-Regulated Metabolic Diseases and Related Drug Discoveries |
| Q92240820 | Network Pharmacology-Based Prediction of the Active Compounds, Potential Targets, and Signaling Pathways Involved in Danshiliuhao Granule for Treatment of Liver Fibrosis |
| Q96167082 | Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/FoxO pathway |
Search more.